Citadel Advisors’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.17M | Sell |
103,244
-4,318
| -4% | -$49K | ﹤0.01% | 3150 |
|
2025
Q1 | $715K | Buy |
107,562
+14,982
| +16% | +$99.6K | ﹤0.01% | 3638 |
|
2024
Q4 | $1.02M | Buy |
92,580
+85,630
| +1,232% | +$944K | ﹤0.01% | 3230 |
|
2024
Q3 | $85.4K | Buy |
+6,950
| New | +$85.4K | ﹤0.01% | 4984 |
|
2024
Q2 | – | Hold |
0
| – | – | – | 6772 |
|
2024
Q1 | – | Sell |
-15,577
| Closed | -$81.9K | – | 6801 |
|
2023
Q4 | $81.9K | Sell |
15,577
-60,543
| -80% | -$318K | ﹤0.01% | 4946 |
|
2023
Q3 | $300K | Sell |
76,120
-96,178
| -56% | -$379K | ﹤0.01% | 4255 |
|
2023
Q2 | $1.83M | Sell |
172,298
-52,167
| -23% | -$555K | ﹤0.01% | 2493 |
|
2023
Q1 | $1.87M | Sell |
224,465
-85,041
| -27% | -$708K | ﹤0.01% | 2602 |
|
2022
Q4 | $2.86M | Buy |
309,506
+37,725
| +14% | +$348K | ﹤0.01% | 2266 |
|
2022
Q3 | $3.49M | Buy |
271,781
+146,544
| +117% | +$1.88M | ﹤0.01% | 2194 |
|
2022
Q2 | $1.65M | Sell |
125,237
-3,295
| -3% | -$43.5K | ﹤0.01% | 2922 |
|
2022
Q1 | $2.71M | Buy |
128,532
+120,110
| +1,426% | +$2.53M | ﹤0.01% | 2681 |
|
2021
Q4 | $202K | Sell |
8,422
-20,945
| -71% | -$502K | ﹤0.01% | 5474 |
|
2021
Q3 | $747K | Sell |
29,367
-29,765
| -50% | -$757K | ﹤0.01% | 4096 |
|
2021
Q2 | $1.99M | Buy |
59,132
+26,802
| +83% | +$902K | ﹤0.01% | 3225 |
|
2021
Q1 | $1.26M | Buy |
+32,330
| New | +$1.26M | ﹤0.01% | 3673 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 5566 |
|
2020
Q3 | – | Hold |
0
| – | – | – | 5236 |
|
2020
Q2 | – | Sell |
-18,865
| Closed | -$432K | – | 5265 |
|
2020
Q1 | $432K | Buy |
18,865
+8,400
| +80% | +$192K | ﹤0.01% | 3513 |
|
2019
Q4 | $296K | Buy |
+10,465
| New | +$296K | ﹤0.01% | 3884 |
|
2019
Q3 | – | Sell |
-99,818
| Closed | -$2.91M | – | 5113 |
|
2019
Q2 | $2.91M | Buy |
+99,818
| New | +$2.91M | ﹤0.01% | 2110 |
|